Extract from the Register of European Patents

EP About this file: EP0620003

EP0620003 - VASOPRESSIN ANTAGONIST AND OXYTOCIN ANTAGONIST [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  21.11.2008
Database last updated on 08.04.2026
Most recent event   Tooltip21.11.2008No opposition filed within time limitpublished on 24.12.2008  [2008/52]
Applicant(s)For all designated states
OTSUKA PHARMACEUTICAL CO., LTD.
9, Kandatsukasa-cho 2-chome Chiyoda-ku
Tokyo 101-0048 / JP
[2008/03]
Former [1994/42]For all designated states
OTSUKA PHARMACEUTICAL CO., LTD.
9, Kandatsukasa-cho 2-chome
Chiyoda-ku Tokyo 101 / JP
Inventor(s)01 / OGAWA, Hidenori
25-18, Aza Nakase Nishinokoshi Nakakirai
Matsushigecho Itano-gun Tokushima 771-02 / JP
02 / KONDO, Kazumi
55-11, Aza Inamoto Nakakirai Matsushigecho
Itano-gun Tokushima 771-02 / JP
03 / YAMASHITA, Hiroshi
57-1, Aza Hachikami Sasakino Matsushigecho
Itano-gun Tokushima 771-02 / JP
04 / NAKAYA, Kenji
48, Kamibekku kita Kawauchicho
Tokushima-shi Tokushima 771-01 / JP
05 / KOMATSU, Hajime
14-16, Umegoaka 3-chome
Setagaya-ku Tokyo 154 / JP
06 / TANAKA, Michinori
211-1, Aza Inamoto Nakakirai Matsushigecho
Itano-gun Tokushima 771-02 / JP
07 / KITANO, Kazuyoshi
463-10, Kagasuno Kawauchicho
Tokushima-shi Tokushima 771-01 / JP
08 / TOMINAGA, Michiaki
310-6, Takaiso Kamiitacho
Itano-gun Tokushima 771-13 / JP
09 / YABUUCHI, Yoichi
900-25, Ohmatsu Kawauchicho
Tokushima-shi Tokushima 771-01 / JP
[1994/42]
Representative(s)Hansen, Bernd, et al
Hoffmann Eitle Patent- und Rechtsanwälte Arabellastrasse 4
81925 München / DE
[N/P]
Former [1994/42]Hansen, Bernd, Dr. Dipl.-Chem., et al
Hoffmann, Eitle & Partner, Patentanwälte, Arabellastrasse 4
D-81925 München / DE
Application number, filing date93922637.915.10.1993
[1994/42]
WO1993JP01483
Priority number, dateJP1992027758916.10.1992         Original published format: JP 27758992
[1994/42]
Filing languageJA
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO9408582
Date:28.04.1994
Language:EN
[1994/10]
Type: A1 Application with search report 
No.:EP0620003
Date:19.10.1994
Language:EN
The application published by WIPO in one of the EPO official languages on 28.04.1994 takes the place of the publication of the European patent application.
[1994/42]
Type: B1 Patent specification 
No.:EP0620003
Date:16.01.2008
Language:EN
[2008/03]
Search report(s)International search report - published on:JP28.04.1994
(Supplementary) European search report - dispatched on:EP05.01.1995
ClassificationIPC:A61K31/55, A61K31/60, C07D223/16, C07D401/00, C07D403/00, C07D405/00
[1994/42]
CPC:
C07D223/16 (EP,US); A61P7/02 (EP); A61P9/00 (EP);
A61P9/08 (EP); C07D231/12 (EP,US); C07D233/56 (EP,US);
C07D249/08 (EP,US); C07D401/06 (EP,US); C07D401/12 (EP,US);
C07D403/06 (EP,US); C07D403/12 (EP,US); C07D405/12 (EP,US) (-)
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FR,   GB,   IE,   IT,   LI,   LU,   NL,   SE [1994/42]
TitleGerman:VASOPRESSIN ANTAGONIST UND OXYTOCIN ANTAGONIST[1994/42]
English:VASOPRESSIN ANTAGONIST AND OXYTOCIN ANTAGONIST[1994/42]
French:ANTAGONISTE DE LA VASOPRESSINE ET ANTAGONISTE DE L'OCYTOCINE[1994/42]
Entry into regional phase08.06.1994Translation filed 
08.06.1994National basic fee paid 
08.06.1994Search fee paid 
08.06.1994Designation fee(s) paid 
08.06.1994Examination fee paid 
Examination procedure08.06.1994Examination requested  [1994/42]
07.09.2001Despatch of a communication from the examining division (Time limit: M04)
17.01.2002Reply to a communication from the examining division
28.03.2003Despatch of a communication from the examining division (Time limit: M06)
22.09.2003Reply to a communication from the examining division
28.07.2004Despatch of a communication from the examining division (Time limit: M04)
06.12.2004Reply to a communication from the examining division
11.03.2005Despatch of a communication from the examining division (Time limit: M04)
15.07.2005Reply to a communication from the examining division
09.06.2006Despatch of a communication from the examining division (Time limit: M06)
19.12.2006Reply to a communication from the examining division
05.01.2007Despatch of a communication from the examining division (Time limit: M04)
14.05.2007Reply to a communication from the examining division
06.08.2007Communication of intention to grant the patent
26.11.2007Fee for grant paid
26.11.2007Fee for publishing/printing paid
Divisional application(s)EP07021546.2  / EP1902717
Opposition(s)17.10.2008No opposition filed within time limit [2008/52]
Fees paidRenewal fee
30.10.1995Renewal fee patent year 03
31.10.1996Renewal fee patent year 04
29.10.1997Renewal fee patent year 05
30.10.1998Renewal fee patent year 06
21.10.1999Renewal fee patent year 07
18.10.2000Renewal fee patent year 08
19.10.2001Renewal fee patent year 09
30.10.2002Renewal fee patent year 10
22.10.2003Renewal fee patent year 11
25.10.2004Renewal fee patent year 12
24.10.2005Renewal fee patent year 13
25.10.2006Renewal fee patent year 14
25.10.2007Renewal fee patent year 15
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[P]   Regul. Pept., 45(1-2), 295-298 (1993). [P]
 [X]   J. Pharmacol. Exp. Ther., 263(2), 627-631 (1992). [X]
 [X]   Br. J. Pharmacol., 105(4), 787-791 (1992). [X]
 [X]   Lecture Summaries of Discussion on Natural Organic Compound (the 33rd) 228-235 (1991). [X]
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.